Use of commonly available OTC nasal sprays reduces the severity of, and shortens the length of time people suffer from, respiratory illnesses, a recently-published study has found.
By treating the symptoms of such illnesses, which are mostly viral in origin, the nasal sprays studied – Procter and Gamble’s gel-based antiviral Vicks First Defence spray and Venture Life’s Sterinase saline spray – also have
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?